Generics 5

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Baricitinib manufacturers

5 products found

Filters

5 products found

baricitinib

Tablets, film coated 2 mg, 4 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
Egypt
GMP approvals
WHO
Comments
Will be available in Q3-2024
Manufacturer #274
This pharmaceutical company, established over three decades ago, boasts a strong presence across numerous regions, including the Middle East and Africa. The company's portfolio encompasses a wide range of products, including prescription and over-the-counter medications, as well as food supplements. Their manufacturing facilities adhere to stringent quality standards, boasting EU and US GMP certifications. The company is known for its dedication to research and development, reflected in its numerous product patents. Their key therapeutic areas include infectious diseases, cardiovascular health, and anti-viral therapies. This commitment to innovation has resulted in a significant impact on patient care, particularly in the field of hepatitis C treatment.

Manufacturer usually replies in 1 days

baricitinib

Tablets 20 mg, 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340
The company is a leading conglomerate with a diverse range of business operations across multiple industries. The website is structured to provide detailed financial information through sections like “Annual Report,” “Quarterly Report,” and “Price Sensitive Information,” which include links to various reports from recent years and updates on financial performance, such as notices about bond issuances. The company operates in several key sectors, including textiles, pharmaceuticals, personal protective equipment (PPE), ceramics, information and communication technology (ICT), real estate and trading, media, financial services, energy, and travel and tourism. As the largest entity within its group, the company plays a significant role in driving economic activities and growth across these industries, reflecting its strong market presence and commitment to diversified business interests.

Manufacturer usually replies in 8 days

baricitinib

Tablets, film coated 2 mg, 4 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
EU GMP
Comments
Ref. Olumiant / Eli Lilly PRODUCT PROTECTION EXPIRATION (EU): 2032
Manufacturer #13072
This pharmaceutical company, established in 1958, boasts a long history and operates across multiple regions, including Europe and North America. They specialize in the production of prescription medications, with a focus on three key therapy areas: oncology, immunology, and dermatology. Their principal dosage forms include tablets, capsules, and topical solutions. The company possesses GMP certifications and holds patents for several product innovations. With three production facilities and a logistics center, they prioritize efficiency and international expansion, aiming to become a global leader in the pharmaceutical industry.

Manufacturer usually replies in 29 days

Want to see all 5 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible